The added value of H2 antagonists in premedication regimens during paclitaxel treatment.
Cox JM, van Doorn L, Malmberg R, Oomen-de Hoop E, Bosch TM, van den Bemt PMLA, Boere IA, Jager A, Mathijssen RHJ, van Leeuwen RWF.
Cox JM, et al. Among authors: bosch tm.
Br J Cancer. 2021 May;124(10):1647-1652. doi: 10.1038/s41416-021-01313-0. Epub 2021 Mar 24.
Br J Cancer. 2021.
PMID: 33762718
Free PMC article.
Clinical Trial.